Amniotic fluid stem cells (AFSc) are a very heterogeneous subtype of stem cells. These cells have a very broad potential, they can differentiate from mesenchymal to even neuro-ectodermal lineages. In the past years mesangioblasts, pericytes of the skeletal muscle, were characterized as muscle progenitor cells and they were discovered to have the potential to generate myoblast in vitro and to repair damaged muscle in vivo. In this study we investigated the in vitro myogenic potential of these cells and their effect on cardiotoxin induced muscle injury.
Methods
Sixteen monoclonal cell lines derived from amniotic fluid were characterized for Alkaline Phosphatase Activity (ALP) and for the canonical pericytes markers NG2, PDGFRα, PDGFRβ, α-SMA and CD13. 2 cell lines were subsequently differentiated in a muscle lineage with specific myogenic differentiation medium for 7 days in hypoxic conditions (5% O2). The same cell lines were genetically modified by lentiviral transduction to express GFP and LacZ and used in a co-culture system with the myoblast murine cell line C2C12. Cells were then visualized after integration into the formed myotubes. To test the in vivo potential, 500, 000 AFSc were injected into the muscle of the right tibialis anterior (TA) muscle in 3 Rag2-/-mice 48 hours after cardiotoxin injection and in the left TA without cardiotoxin. The sham group consisted of 3 animals with injection of cardiotoxin in the right TA and with vehicle in the left leg. 3 uninjected animals were used as controls. Muscle biopsy was performed 2 weeks after injection and processed for X-gal staining and for laminin expression. Fiber size was calculated to detect muscle regeneration.
Results
5 of 16 monoclonal cell lines were highly positive for ALP and for pericyte markers. AFSc with high expression profiles were cultured with differentiated medium and were able to form myotubes. They were also able to integrate into myotubes when co-cultured with C2C12 cells. AFSc were found in injured and non-injured TA muscles. Cardiotoxin injured muscles recovered after injection of AFSc with a reduction in the fibrotic area and with recovery of the perimeter/area of fiber cross section.
Conclusion
Our data suggest that AFSc share some characteristic with periciyte cells and have myogenic potential in vitro and can induce morphological regeneration in injured muscle in vivo.
